WorldQuant Millennium Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

WorldQuant Millennium Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.48M	Sell	23,677 -4,707	-17%	-$823K	0.02%	347
2025 Q4	$4.83M	Buy	+28,384	New	+$4.35M	0.02%	335
2025 Q1	–	Sell	-4,775	Closed	-$588K	–	464
2024 Q4	$588K	Hold	4,775	–	–	﹤0.01%	399
2024 Q3	$532K	Hold	4,775	–	–	﹤0.01%	398
2024 Q2	$510K	Sell	4,775 -44,009	-90%	-$4.84M	﹤0.01%	373
2024 Q1	$5.87M	Sell	48,784 -116,185	-70%	-$14.2M	0.07%	233
2023 Q4	$20.3M	Buy	164,969 +65,638	+66%	+$8.19M	0.28%	111
2023 Q3	$12.9M	Sell	99,331 -13,179	-12%	-$1.76M	0.2%	149
2023 Q2	$13.9M	Buy	112,510 +53,030	+89%	+$7.13M	0.24%	140
2023 Q1	$8.7M	Buy	+59,480	New	+$8.8M	0.16%	173
2020 Q1	–	Sell	-10,942	Closed	-$1.63M	–	338
2019 Q4	$1.63M	Sell	10,942 -781	-7%	-$106K	0.03%	275
2019 Q3	$1.5M	Sell	11,723 -364	-3%	-$48.8K	0.03%	268
2019 Q2	$1.72M	Buy	12,087 +1,516	+14%	+$204K	0.03%	236
2019 Q1	$1.51M	Buy	+10,571	New	+$1.38M	0.04%	237

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

WorldQuant Millennium Advisors's JAZZ Position: Q1 2026 in Review

WorldQuant Millennium Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 17% in Q1 2026, selling an estimated $823K and leaving 23,677 shares worth $4.48M. The position accounts for 0.02% of the portfolio, ranked #347.

WorldQuant Millennium Advisors first reported a position in JAZZ in Q1 2019 and has held it in 14 quarters since. The position peaked at $20.3M in Q4 2023. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

WorldQuant Millennium Advisors held 23,677 shares of Jazz Pharmaceuticals worth $4.48M as of Q1 2026.
WorldQuant Millennium Advisors sold 4,707 Jazz Pharmaceuticals shares in Q1 2026, an estimated $823K.
Jazz Pharmaceuticals made up 0.02% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #347 holding.
WorldQuant Millennium Advisors first reported a position in Jazz Pharmaceuticals in Q1 2019 and has held it in 14 quarters since.
WorldQuant Millennium Advisors's Jazz Pharmaceuticals position peaked at $20.3M in Q4 2023.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.